ZA974785B - Growth hormone and estrogen in the treatment of osteoporosis. - Google Patents

Growth hormone and estrogen in the treatment of osteoporosis.

Info

Publication number
ZA974785B
ZA974785B ZA9704785A ZA974785A ZA974785B ZA 974785 B ZA974785 B ZA 974785B ZA 9704785 A ZA9704785 A ZA 9704785A ZA 974785 A ZA974785 A ZA 974785A ZA 974785 B ZA974785 B ZA 974785B
Authority
ZA
South Africa
Prior art keywords
estrogen
osteoporosis
treatment
growth hormone
hormone
Prior art date
Application number
ZA9704785A
Other languages
English (en)
Inventor
Erik Fink Eriksen
Anne-Marie Kappelgaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA974785B publication Critical patent/ZA974785B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
ZA9704785A 1996-05-31 1997-05-30 Growth hormone and estrogen in the treatment of osteoporosis. ZA974785B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK62396 1996-05-31

Publications (1)

Publication Number Publication Date
ZA974785B true ZA974785B (en) 1998-01-22

Family

ID=8095682

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704785A ZA974785B (en) 1996-05-31 1997-05-30 Growth hormone and estrogen in the treatment of osteoporosis.

Country Status (14)

Country Link
EP (1) EP0907374A1 (pt)
JP (1) JP2000512274A (pt)
KR (1) KR20000016204A (pt)
CN (1) CN1220609A (pt)
AU (1) AU3025997A (pt)
BR (1) BR9709499A (pt)
CA (1) CA2257174A1 (pt)
CZ (1) CZ383298A3 (pt)
HU (1) HUP9904049A3 (pt)
IL (1) IL126983A0 (pt)
NO (1) NO985573L (pt)
PL (1) PL330239A1 (pt)
WO (1) WO1997046252A1 (pt)
ZA (1) ZA974785B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
GB2324726A (en) * 1997-05-01 1998-11-04 Merck & Co Inc Combination Therapy for the Treatment of Osteoporosis
EP1093463A1 (en) * 1998-06-09 2001-04-25 Novo Nordisk A/S A method for preparing a compound with growth hormone releasing properties
US6784158B1 (en) 1998-06-09 2004-08-31 Novo Nordisk A/S Method for preparing a compound with growth hormone releasing properties
JP2001031635A (ja) 1999-07-14 2001-02-06 Ajinomoto Co Inc 光学活性ｎ−保護−ｎ−メチル−フェニルアラニン誘導体の製造方法
ATE446758T1 (de) 2000-05-31 2009-11-15 Pfizer Prod Inc Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
EP2118080B1 (en) 2007-02-09 2016-08-31 Ocera Therapeutics, Inc. Macrocyclic ghrelin receptor modulators and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ236618A (en) * 1990-01-03 1997-06-24 Ciba Geigy Ag Treating and preventing osteoporosis using insulin-like growth factor i (igf i) in conjunction with a bone antiresorptive active compound
JP2557779B2 (ja) * 1990-11-26 1996-11-27 アール． レッカー，ロバート ２成分型骨粗鬆症用薬剤
PL314003A1 (en) * 1993-10-19 1996-08-05 Merck & Co Inc Combination of bisulphonates and substances enhancing secretion of growth hormone

Also Published As

Publication number Publication date
IL126983A0 (en) 1999-09-22
AU3025997A (en) 1998-01-05
CA2257174A1 (en) 1997-12-11
CZ383298A3 (cs) 1999-07-14
KR20000016204A (ko) 2000-03-25
CN1220609A (zh) 1999-06-23
NO985573L (no) 1999-01-29
EP0907374A1 (en) 1999-04-14
JP2000512274A (ja) 2000-09-19
PL330239A1 (en) 1999-05-10
WO1997046252A1 (en) 1997-12-11
HUP9904049A2 (hu) 2000-04-28
NO985573D0 (no) 1998-11-27
HUP9904049A3 (en) 2000-07-28
BR9709499A (pt) 1999-08-10

Similar Documents

Publication Publication Date Title
AU5176898A (en) Integrated bone cement mixing and dispensing system
EP0741578A4 (en) HUMAN GROWTH HORMONE
AU3218197A (en) Natural progesterone for the treatment of side effects of progestins and progesterone analogues
ZA987385B (en) Growth hormone secretagogues.
GB2319912B (en) Oscillator and method for controlling the same
ZA979011B (en) Hormonal composition and its use.
ZA974785B (en) Growth hormone and estrogen in the treatment of osteoporosis.
EP0890599A4 (en) POLYORGANOSILOXANES AND METHOD FOR THE PRODUCTION THEREOF
HUP9904175A3 (en) Human growth gene and short stature gene region
IL115224A0 (en) Preparations for use in the treatment of osteoporosis
PL331523A1 (en) Azolotrizines and azolopyrimidines
GB9616700D0 (en) Hormone supplement
ZA9711148B (en) Bone stimulating factor.
IL120265A0 (en) Combination therapy to treat osteoporosis - polyphosphonates or progestins and estrogen agonists
ZA9711047B (en) Formulation and use.
ZA971718B (en) Combination therapy to prevent bone loss-progesterone and estrogen agonists
AUPO350296A0 (en) Mixing and transporting device
IL134282A0 (en) Inhibition of unwanted hormone action in plants
PL331283A1 (en) Preparation for treating and/or preventing stupefaction
EP1032266A4 (en) USE OF DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DION IN THE TREATMENT OF ARTHRITIS
HUP9900068A3 (en) Fuse-switch and/or fuse-disconnector
AU6409598A (en) An improvement in the treatment of wastes
GB2309559B (en) Microprocessor and system
AUPP582198A0 (en) Modified human growth hormone
SI0935469T1 (en) Use of growth hormone